UTHR
United Therapeutics Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
United Therapeutics Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
United Therapeutics has 19 disclosed suppliers and 7 disclosed customers in SEC filings.
SentenceWe have a license agreement with United Therapeutics Corporation to use one of our proprietary technologies in an oral formulation of treprostinil diethanolamine, or treprostinil, for the treatment of pulmonary arterial hypertension and for other indications.
SentenceUnder our agreement with Arena Pharmaceuticals, Inc., we will owe a low double-digit, tiered royalty on net product sales of ralinepag (for any route of administration), plus certain milestone payments upon defined regulatory events.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe rely entirely on DEKA and its affiliates to manufacture the Remunity and RemunityPRO Pumps.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe pay DEKA product fees and a single-digit royalty on net product sales of the Remunity and RemunityPRO Pumps and Remodulin for use with these pumps.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe rely on two contract manufacturers — Forj Medical and Phillips-Medisize Corp. — to manufacture the Tyvaso Inhalation System for Nebulized Tyvaso.
UTHR 10-Kaccession 0001082554-26-000006
SentenceIn June 2023, our third-party contract manufacturer, Gilero LLC, which was later acquired by Sanner GmbH, obtained FDA clearance for a cartridge to be used with the MS-3 pump for subcutaneous infusion of Remodulin.
UTHR 10-Kaccession 0001082554-26-000006
SentenceJohns Hopkins University ( JHU ), New York University ( NYU ), the University of Alabama at Birmingham ( UAB ), and the University of Maryland, Baltimore ( UMB ) performed preclinical testing of our porcine xenografts in animal models.
UTHR 10-Kaccession 0001082554-26-000006
SentenceJohns Hopkins University ( JHU ), New York University ( NYU ), the University of Alabama at Birmingham ( UAB ), and the University of Maryland, Baltimore ( UMB ) performed preclinical testing of our porcine xenografts in animal models.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe rely on two contract manufacturers — Forj Medical and Phillips-Medisize Corp. — to manufacture the Tyvaso Inhalation System for Nebulized Tyvaso.
UTHR 10-Kaccession 0001082554-26-000006
SentenceIn October 2024, we entered into a collaboration agreement with Robinson Helicopter Company to support our efforts to develop and certify zero-emission, hydrogen-electric powered helicopters based on Robinson's R44 and R66 helicopter models.
UTHR 10-Kaccession 0001082554-26-000006
SentenceFinally, we rely entirely on Sanner GmbH to manufacture cartridges that were cleared by the FDA for use with the MS-3 pump to administer Remodulin.
UTHR 10-Kaccession 0001082554-26-000006
SentenceIn response, we funded Smiths Medical's manufacture of several thousand additional MS-3 pumps and, in parallel, pursued development of the Remunity Pump so that PAH patients would not experience a delay or disruption in their Remodulin therapy .
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe also pay The Scripps Research Institute a one percent royalty on sales of Unituxin.
UTHR 10-Kaccession 0001082554-26-000006
SentenceIn the United States, we derive substantially all our treprostinil-based revenues from sales to two distributors, Accredo and CVS Specialty.
UTHR 10-Kaccession 0001082554-26-000006
SentenceUnder this agreement, we sell Unituxin to Cencora at a transfer price that we establish, and we pay Cencora fees for services provided in connection with the distribution and support of Unituxin.
UTHR 10-Kaccession 0001082554-26-000006
SentenceIn the United States, we derive substantially all our treprostinil-based revenues from sales to two distributors, Accredo and CVS Specialty.
UTHR 10-Kaccession 0001082554-26-000006
SentenceOur primary distributor outside the United States is Grupo Ferrer Internacional, S.A. ( Ferrer ), which holds Remodulin marketing authorization rights in many of these territories.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe also sell Nebulized Tyvaso exclusively through Mochida Pharmaceutical Co., Ltd. ( Mochida ), in Japan, where the product was approved to treat PAH in late 2022, and to treat PH-ILD in 2024.
UTHR 10-Kaccession 0001082554-26-000006
SentenceWe distribute Unituxin in Japan exclusively through Ohara Pharmaceutical Co., Ltd., which obtained Japanese marketing authorization during the second quarter of 2021.
UTHR 10-Kaccession 0001082554-26-000006
United Therapeutics Corp
597.79
−0.93 · −0.16%
Linked news
Expected move
Inputs8Q avg ±5.8%·×0.71·cheap
straddle ±6.5%
spot 598.72exp Nov 20ATM strike 600ATM straddle 45.75IV 40%